These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation. Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109 [TBL] [Abstract][Full Text] [Related]
26. Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study. Aalten J; Bemelman FJ; van den Berg-Loonen EM; Claas FH; Christiaans MH; de Fijter JW; Hepkema BG; Hené RJ; van der Heide JJ; van Hooff JP; Lardy NM; Lems SP; Otten HG; Weimar W; Allebes WA; Hoitsma AJ Nephrol Dial Transplant; 2009 Aug; 24(8):2559-66. PubMed ID: 19474284 [TBL] [Abstract][Full Text] [Related]
27. Pregnancy in kidney transplant recipients. Pour-Reza-Gholi F; Nafar M; Farrokhi F; Entezari A; Taha N; Firouzan A; Einollahi B Transplant Proc; 2005 Sep; 37(7):3090-2. PubMed ID: 16213315 [TBL] [Abstract][Full Text] [Related]
28. Is positive flow cytometric cross-match a risk factor for early cadaveric kidney graft dysfunction? Piatosa B; Rubik J; Grenda R Transplant Proc; 2006; 38(1):53-5. PubMed ID: 16504662 [TBL] [Abstract][Full Text] [Related]
29. Using the mimetic epitope concept to find a possible way to widen the graft-survival difference between matched and mismatched renal transplants. Sasaki N; Idica A; Hall B; Terasaki PI Clin Transpl; 2008; ():241-52. PubMed ID: 19711515 [TBL] [Abstract][Full Text] [Related]
30. Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: resolution of rejection in the presence of circulating donor-specific antibody. Higgins R; Hathaway M; Lowe D; Lam F; Kashi H; Tan LC; Imray C; Fletcher S; Zehnder D; Chen K; Krishnan N; Hamer R; Briggs D Transplantation; 2007 Oct; 84(7):876-84. PubMed ID: 17984841 [TBL] [Abstract][Full Text] [Related]
31. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience. Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983 [TBL] [Abstract][Full Text] [Related]
32. Preemptive kidney transplantation of living related or unrelated donor-recipient combinations. Ishikawa N; Yagisawa T; Sakuma Y; Fujiwara T; Nukui A; Yashi M; Miyamoto N Transplant Proc; 2008 Sep; 40(7):2294-6. PubMed ID: 18790216 [TBL] [Abstract][Full Text] [Related]
34. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development. Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI Clin Transpl; 2006; ():241-53. PubMed ID: 18365382 [TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience. Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014 [TBL] [Abstract][Full Text] [Related]
36. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant. Aubert V; Venetz JP; Pantaleo G; Pascual M Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474 [TBL] [Abstract][Full Text] [Related]
37. [Desensitization protocols in immunized living donor kidney transplant recipients]. Nocera A G Ital Nefrol; 2009; 26(4):499-515. PubMed ID: 19644839 [TBL] [Abstract][Full Text] [Related]
38. Kidney transplantation in Libya: a North African and Middle Eastern perspective. Ehtuish EF; Abouna GM; Shebani AH; Abdulmola TS; Shawesh TZ Exp Clin Transplant; 2006 Jun; 4(1):425-8. PubMed ID: 16827638 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens. Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814 [TBL] [Abstract][Full Text] [Related]
40. Present status of ABO-incompatible kidney transplantation in Japan. Takahashi K; Saito K Xenotransplantation; 2006 Mar; 13(2):118-22. PubMed ID: 16623804 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]